NorthCrest Asset Manangement’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-643
Closed -$5.53K 647
2025
Q1
$5.53K Buy
+643
New +$5.53K ﹤0.01% 589